Pacira BioSciences, Inc.
PCRX
$26.30
$0.311.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -200.73% | -70.00% | 111.18% | -859.64% | 110.34% |
| Total Depreciation and Amortization | 29.07% | -0.35% | 4.89% | 7.37% | 2.37% |
| Total Amortization of Deferred Charges | 0.58% | -0.12% | 0.58% | 9.80% | 11.49% |
| Total Other Non-Cash Items | 263.66% | -61.74% | -88.91% | 812.62% | 48.17% |
| Change in Net Operating Assets | -3,221.08% | 105.03% | -1,265.33% | 147.62% | -154.07% |
| Cash from Operations | -66.12% | 7.02% | -38.55% | 1.28% | 8.42% |
| Capital Expenditure | 68.45% | -303.59% | 48.24% | -157.36% | 43.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17,213.46% | -121.66% | 103.64% | -252.81% | -7.33% |
| Cash from Investing | 342.55% | -6,864.40% | 99.29% | -242.84% | 2.03% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -33.31% | -0.04% | 0.04% | 98.61% | -7,096.84% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -30,465.75% | -135.06% | -140.63% | 99.87% | -634,350.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | -1,820.67% | -53.15% | 31.28% | -111.39% | 986.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 146.84% | -77.81% | 2,931.71% | -101.73% | 104.85% |